Generating Alloantigen-Specific Regulatory T Cells for Immunotherapy
Author Information
Author(s): Peters Jorieke H., Hilbrands Luuk B., Koenen Hans J. P. M., Joosten Irma
Primary Institution: Radboud University Nijmegen Medical Centre
Hypothesis
Combining polyclonal stimulation with alloantigen stimulation will yield high numbers of Treg with direct alloantigen-specificity.
Conclusion
The study successfully developed a protocol for generating alloantigen-specific Treg that can enhance the success of clinical immunotherapy.
Supporting Evidence
- Regulatory T cell (Treg) based immunotherapy is a potential treatment for several immune disorders.
- Efficient increases in cell numbers were obtained through the described expansion protocol.
- Treg expanded with alloantigen stimulation showed very high suppressive activity in target antigen driven responses.
Takeaway
Scientists figured out how to grow special immune cells that can help prevent organ rejection in transplants by making them specific to the donor's cells.
Methodology
The study used two stimulation cycles with HLA mismatched allogeneic stimulator cells and T cell growth factors to generate Treg.
Potential Biases
Potential contamination with other T cell types during the expansion process.
Limitations
The study did not explore the long-term effects of the generated Treg in clinical settings.
Participant Demographics
Healthy human donors provided the buffy coats used for Treg isolation.
Statistical Information
P-Value
0.025
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website